1. Home
  2. KTB vs AMRX Comparison

KTB vs AMRX Comparison

Compare KTB & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KTB
  • AMRX
  • Stock Information
  • Founded
  • KTB 2018
  • AMRX 2002
  • Country
  • KTB United States
  • AMRX United States
  • Employees
  • KTB N/A
  • AMRX N/A
  • Industry
  • KTB Apparel
  • AMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • KTB Consumer Discretionary
  • AMRX Health Care
  • Exchange
  • KTB Nasdaq
  • AMRX Nasdaq
  • Market Cap
  • KTB 3.0B
  • AMRX 2.4B
  • IPO Year
  • KTB N/A
  • AMRX N/A
  • Fundamental
  • Price
  • KTB $68.56
  • AMRX $7.41
  • Analyst Decision
  • KTB Strong Buy
  • AMRX Strong Buy
  • Analyst Count
  • KTB 5
  • AMRX 5
  • Target Price
  • KTB $84.80
  • AMRX $10.80
  • AVG Volume (30 Days)
  • KTB 658.3K
  • AMRX 2.1M
  • Earning Date
  • KTB 05-06-2025
  • AMRX 05-02-2025
  • Dividend Yield
  • KTB 3.04%
  • AMRX N/A
  • EPS Growth
  • KTB 3.07
  • AMRX N/A
  • EPS
  • KTB 4.07
  • AMRX N/A
  • Revenue
  • KTB $2,599,277,000.00
  • AMRX $2,830,186,000.00
  • Revenue This Year
  • KTB $2.55
  • AMRX $10.49
  • Revenue Next Year
  • KTB $2.39
  • AMRX $7.00
  • P/E Ratio
  • KTB $16.83
  • AMRX N/A
  • Revenue Growth
  • KTB 1.08
  • AMRX 13.42
  • 52 Week Low
  • KTB $50.00
  • AMRX $5.18
  • 52 Week High
  • KTB $96.80
  • AMRX $9.48
  • Technical
  • Relative Strength Index (RSI)
  • KTB 65.15
  • AMRX 46.13
  • Support Level
  • KTB $61.18
  • AMRX $7.15
  • Resistance Level
  • KTB $70.08
  • AMRX $8.02
  • Average True Range (ATR)
  • KTB 2.17
  • AMRX 0.32
  • MACD
  • KTB 1.35
  • AMRX 0.02
  • Stochastic Oscillator
  • KTB 88.11
  • AMRX 31.07

About KTB Kontoor Brands Inc.

Kontoor Brands Inc is a lifestyle apparel company. It is engaged in designing, manufacturing, sourcing, marketing, and distribution of its portfolio of brands, including Wrangler and Lee. It manufactures its products in owned and leased facilities and distributes the products through both brick-and-mortar and e-commerce retailers. The Company has two reportable segments: Wrangler and Lee. It generates the majority of its revenue from the Wrangler segment. The company's geographical segments are the United States and International, of which the majority of its revenue comes from the United States.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: